ReviewPhytotherapy research : PTR2016
Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed).
Review in Phytotherapy research : PTR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 81 citations in OpenAlex.
- Article
- Proteogenomic investigation of plant constituents in herbal beverages.NPJ science of food · 2026Article
- Documenting traditional knowledge of the Trans-Himalaya: ethnic uses of plants in Drass valley, Ladakh.Journal of ethnobiology and ethnomedicine · 2025Article
- Reduced function in Chamaenerion angustifolium after sublethal glyphosate exposure.Scientific reports · 2025Article
- Antioxidant and Preservative Effects ofFood science & nutrition · 2025Article
- Exploring the Phytochemical Profile and Biological Insights ofPlants (Basel, Switzerland) · 2025Article
- The phenology ofFrontiers in pharmacology · 2025Article
- Anti-cancer Properties of Epigallocatechin-3-gallate (EGCG) and its Signaling Pathways.Current medicinal chemistry · 2025Review
- The association between dietary antioxidant quality score and intensity and frequency of migraine headaches among women: a cross-sectional study.BMC women's health · 2024Article
- Polymodal KCommunications biology · 2024Article
- Investigation ofPlants (Basel, Switzerland) · 2024Article
- Phenological Variations in the Content of Polyphenols and Triterpenoids inPlants (Basel, Switzerland) · 2023Article
- Antibacterial and Antimycotic Activity ofPharmaceuticals (Basel, Switzerland) · 2023Review
- The Impact of Solid-Phase Fermentation on Flavonoids, Phenolic Acids, Tannins and Antioxidant Activity inPlants (Basel, Switzerland) · 2023Article
- Effect of Solid-State Fermentation on Vitamin C, Photosynthetic Pigments and Sugars in Willow Herb (Plants (Basel, Switzerland) · 2022Article
- Review
- Biological Activity of anMolecules (Basel, Switzerland) · 2022Article
- Comparative Analysis of the Efficiency of Medicinal Plants for the Treatment and Prevention of COVID-19.International journal of biomaterials · 2022Review
- Isolation, Chemical Characterization and Antioxidant Activity of Pectic Polysaccharides of Fireweed (Molecules (Basel, Switzerland) · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
Epilobium angustifolium is a medicinal plant used around the world in traditional medicine for the treatment of many disorders and ailments. Experimental studies have demonstrated that Epilobium extracts possess a broad range of pharmacological and therapeutic effects, including antioxidant, anti-proliferative, anti-inflammatory, antibacterial, and anti-aging properties. Flavonoids and ellagitannins, such as oenothein B, are among the compounds considered to be the primary biologically active components in Epilobium extracts. In this review, we focus on the biological properties and the potential clinical usefulness of oenothein B, flavonoids, and other polyphenols derived from E. angustifolium. Understanding the biochemical properties and therapeutic effects of polyphenols present in E. angustifolium extracts will benefit further development of therapeutic treatments from this plant. Copyright © 2016 John Wiley & Sons, Ltd.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.